TABLE 6A - NEW DIAGNOSIS CODES
Diagnosis Code	Description	CC	MDC	MS-DRG
C78.31	Secondary malignant neoplasm of larynx	C	04	180, 181, 182
C78.32	Secondary malignant neoplasm of pharynx	C	04	180, 181, 182
C79.83	Secondary malignant neoplasm of oral cavity	C	17	826, 827, 828, 829, 830, 843, 844, 845
D69.11	Glanzmann thrombasthenia	N	16	813
D69.19	Other qualitative platelet defects	N	16	813
E89.830	Post bariatric hypoglycemia	C	21	919, 920, 921
E89.838	Other postprocedural hypoglycemia	C	21	919, 920, 921
F64.A	Gender identity disorder, in remission	N	19	887
I42.00	Dilated cardiomyopathy, unspecified	C	05	314, 315, 316
I42.01	Familial-genetic dilated cardiomyopathy	C	05	314, 315, 316
I42.09	Other dilated cardiomyopathy	C	05	314, 315, 316
I42.81	Arrhythmogenic cardiomyopathy	C	05	314, 315, 316
I42.89	Other cardiomyopathies not elsewhere classified	C	05	314, 315, 316
I47.22	Catecholaminergic polymorphic ventricular tachycardia [CPVT]	C	05	308, 309, 310
""			15	791(1), 793(1)
I49.81	Brugada syndrome	N	05	308, 309, 310
I49.82	Ventricular bigeminy	N	05	308, 309, 310
I49.89	Other specified cardiac arrhythmias not elsewhere classified	N	05	308, 309, 310
J34.830	Odontogenic sinusitis, maxillary sinus	N	03	154, 155, 156
""			15	795(2)
J34.831	Odontogenic sinusitis, ethmoid sinus	N	03	154, 155, 156
""			15	795(2)
J34.832	Odontogenic sinusitis, frontal sinus	N	03	154, 155, 156
""			15	795(2)
J34.833	Odontogenic sinusitis, sphenoid sinus	N	03	154, 155, 156
""			15	795(2)
J34.839	Odontogenic sinusitis, unspecified	N	03	154, 155, 156
""			15	795(2)
J4B	Pulmonary mycetoma	M	04	177, 178, 179
""			15	791(1), 793(1)
""			25	974(3), 975(3), 976(3)
K31.B	Hypertrophic pyloric stenosis, in childhood	C	06	380, 381, 382
K6A.01	Prevesical abscess	M	06	371, 372, 373
""			15	791(1), 793(1)
K6A.09	Other pelvic abscess	M	06	371, 372, 373
""			15	791(1), 793(1)
K6A.8	Other diseases of the pelvis, not elsewhere classified	C	06	371, 372, 373
""			15	791(1), 793(1)
K74.0A	Hepatic fibrosis, moderate fibrosis	N	07	432, 433, 434
K76.83	Intestinal failure-associated liver disease	N	07	441, 442, 443
L02.237	Carbuncle of flank	N	09	602, 603
M04.3	VEXAS syndrome	N	08	545, 546, 547
M67.A01	Plantar fasciitis, right foot	N	08	557, 558
M67.A02	Plantar fasciitis, left foot	N	08	557, 558
M67.A09	Plantar fasciitis, unspecified foot	N	08	557, 558
M72.20	Plantar fascial fibromatosis, unspecified foot	N	08	557, 558
M72.21	Plantar fascial fibromatosis, right foot	N	08	557, 558
M72.22	Plantar fascial fibromatosis, left foot	N	08	557, 558
M86.8X11	Other osteomyelitis, right shoulder	C	08	539, 540, 541
M86.8X12	Other osteomyelitis, left shoulder	C	08	539, 540, 541
M86.8X19	Other osteomyelitis, unspecified shoulder	C	08	539, 540, 541
M86.8X21	Other osteomyelitis, right upper arm	C	08	539, 540, 541
M86.8X22	Other osteomyelitis, left upper arm	C	08	539, 540, 541
M86.8X29	Other osteomyelitis, unspecified upper arm	C	08	539, 540, 541
M86.8X31	Other osteomyelitis, right forearm	C	08	539, 540, 541
M86.8X32	Other osteomyelitis, left forearm	C	08	539, 540, 541
M86.8X39	Other osteomyelitis, unspecified forearm	C	08	539, 540, 541
M86.8X41	Other osteomyelitis, right hand	C	08	539, 540, 541
M86.8X42	Other osteomyelitis, left hand	C	08	539, 540, 541
M86.8X49	Other osteomyelitis, unspecified hand	C	08	539, 540, 541
M86.8X51	Other osteomyelitis, right thigh	C	08	539, 540, 541
M86.8X52	Other osteomyelitis, left thigh	C	08	539, 540, 541
M86.8X59	Other osteomyelitis, unspecified thigh	C	08	539, 540, 541
M86.8X61	Other osteomyelitis, right lower leg	C	08	400, 539, 540, 541
M86.8X62	Other osteomyelitis, left lower leg	C	08	400, 539, 540, 541
M86.8X69	Other osteomyelitis, unspecified lower leg	C	08	400, 539, 540, 541
M86.8X71	Other osteomyelitis, right ankle and foot	C	08	539, 540, 541
M86.8X72	Other osteomyelitis, left ankle and foot	C	08	539, 540, 541
M86.8X79	Other osteomyelitis, unspecified ankle and foot	C	08	539, 540, 541
M86.8X80	Other osteomyelitis, skull	C	08	456(4), 457(4), 458(4), 539, 540, 541
M86.8X81	Other osteomyelitis, face and sinuses	C	08	456(4), 457(4), 458(4), 539, 540, 541
M86.8X89	Other osteomyelitis, other site	C	08	456(4), 457(4), 458(4), 539, 540, 541
N99.860	Intraoperative and postprocedural nipple ischemia	N	09	600, 601
N99.861	Intraoperative and postprocedural nipple necrosis	N	09	600, 601
O00.121	Right interstitial ectopic pregnancy without intrauterine pregnancy	C	14	817, 818, 819, 831, 832, 833
O00.122	Left interstitial ectopic pregnancy without intrauterine pregnancy	C	14	817, 818, 819, 831, 832, 833
O00.129	Unspecified interstitial ectopic pregnancy without intrauterine pregnancy	C	14	817, 818, 819, 831, 832, 833
O00.131	Right interstitial ectopic pregnancy with intrauterine pregnancy	C	14	817, 818, 819, 831, 832, 833
O00.132	Left interstitial ectopic pregnancy with intrauterine pregnancy	C	14	817, 818, 819, 831, 832, 833
O00.139	Unspecified interstitial ectopic pregnancy with intrauterine pregnancy	C	14	817, 818, 819, 831, 832, 833
O00.31	Cesarean scar ectopic pregnancy without intrauterine pregnancy	C	14	817, 818, 819, 831, 832, 833
O00.32	Cesarean scar ectopic pregnancy with intrauterine pregnancy	C	14	817, 818, 819, 831, 832, 833
O00.41	Cervical ectopic pregnancy without intrauterine pregnancy	C	14	817, 818, 819, 831, 832, 833
O00.42	Cervical ectopic pregnancy with intrauterine pregnancy	C	14	817, 818, 819, 831, 832, 833
O00.511	Right cornual ectopic pregnancy without intrauterine pregnancy	C	14	817, 818, 819, 831, 832, 833
O00.512	Left cornual ectopic pregnancy without intrauterine pregnancy	C	14	817, 818, 819, 831, 832, 833
O00.519	Unspecified cornual ectopic pregnancy without intrauterine pregnancy	C	14	817, 818, 819, 831, 832, 833
O00.521	Right cornual ectopic pregnancy with intrauterine pregnancy	C	14	817, 818, 819, 831, 832, 833
O00.522	Left cornual ectopic pregnancy with intrauterine pregnancy	C	14	817, 818, 819, 831, 832, 833
O00.529	Unspecified cornual ectopic pregnancy with intrauterine pregnancy	C	14	817, 818, 819, 831, 832, 833
O31.40X0	Continuing pregnancy after vanishing twin syndrome of one fetus or more, unspecified trimester, not applicable or unspecified	N	14	817, 818, 819, 831, 832, 833
O31.40X1	Continuing pregnancy after vanishing twin syndrome of one fetus or more, unspecified trimester, fetus 1	N	14	817, 818, 819, 831, 832, 833
O31.40X2	Continuing pregnancy after vanishing twin syndrome of one fetus or more, unspecified trimester, fetus 2	N	14	817, 818, 819, 831, 832, 833
O31.40X3	Continuing pregnancy after vanishing twin syndrome of one fetus or more, unspecified trimester, fetus 3	N	14	817, 818, 819, 831, 832, 833
O31.40X4	Continuing pregnancy after vanishing twin syndrome of one fetus or more, unspecified trimester, fetus 4	N	14	817, 818, 819, 831, 832, 833
O31.40X5	Continuing pregnancy after vanishing twin syndrome of one fetus or more, unspecified trimester, fetus 5	N	14	817, 818, 819, 831, 832, 833
O31.40X9	Continuing pregnancy after vanishing twin syndrome of one fetus or more, unspecified trimester, other fetus	N	14	817, 818, 819, 831, 832, 833
O31.41X0	Continuing pregnancy after vanishing twin syndrome of one fetus or more, first trimester, not applicable or unspecified	N	14	817, 818, 819, 831, 832, 833
O31.41X1	Continuing pregnancy after vanishing twin syndrome of one fetus or more, first trimester, fetus 1	N	14	817, 818, 819, 831, 832, 833
O31.41X2	Continuing pregnancy after vanishing twin syndrome of one fetus or more, first trimester, fetus 2	N	14	817, 818, 819, 831, 832, 833
O31.41X3	Continuing pregnancy after vanishing twin syndrome of one fetus or more, first trimester, fetus 3	N	14	817, 818, 819, 831, 832, 833
O31.41X4	Continuing pregnancy after vanishing twin syndrome of one fetus or more, first trimester, fetus 4	N	14	817, 818, 819, 831, 832, 833
O31.41X5	Continuing pregnancy after vanishing twin syndrome of one fetus or more, first trimester, fetus 5	N	14	817, 818, 819, 831, 832, 833
O31.41X9	Continuing pregnancy after vanishing twin syndrome of one fetus or more, first trimester, other fetus	N	14	817, 818, 819, 831, 832, 833
O31.42X0	Continuing pregnancy after vanishing twin syndrome of one fetus or more, second trimester, not applicable or unspecified	N	14	817, 818, 819, 831, 832, 833
O31.42X1	Continuing pregnancy after vanishing twin syndrome of one fetus or more, second trimester, fetus 1	N	14	817, 818, 819, 831, 832, 833
O31.42X2	Continuing pregnancy after vanishing twin syndrome of one fetus or more, second trimester, fetus 2	N	14	817, 818, 819, 831, 832, 833
O31.42X3	Continuing pregnancy after vanishing twin syndrome of one fetus or more, second trimester, fetus 3	N	14	817, 818, 819, 831, 832, 833
O31.42X4	Continuing pregnancy after vanishing twin syndrome of one fetus or more, second trimester, fetus 4	N	14	817, 818, 819, 831, 832, 833
O31.42X5	Continuing pregnancy after vanishing twin syndrome of one fetus or more, second trimester, fetus 5	N	14	817, 818, 819, 831, 832, 833
O31.42X9	Continuing pregnancy after vanishing twin syndrome of one fetus or more, second trimester, other fetus	N	14	817, 818, 819, 831, 832, 833
O31.43X0	Continuing pregnancy after vanishing twin syndrome of one fetus or more, third trimester, not applicable or unspecified	N	14	817, 818, 819, 831, 832, 833
O31.43X1	Continuing pregnancy after vanishing twin syndrome of one fetus or more, third trimester, fetus 1	N	14	817, 818, 819, 831, 832, 833
O31.43X2	Continuing pregnancy after vanishing twin syndrome of one fetus or more, third trimester, fetus 2	N	14	817, 818, 819, 831, 832, 833
O31.43X3	Continuing pregnancy after vanishing twin syndrome of one fetus or more, third trimester, fetus 3	N	14	817, 818, 819, 831, 832, 833
O31.43X4	Continuing pregnancy after vanishing twin syndrome of one fetus or more, third trimester, fetus 4	N	14	817, 818, 819, 831, 832, 833
O31.43X5	Continuing pregnancy after vanishing twin syndrome of one fetus or more, third trimester, fetus 5	N	14	817, 818, 819, 831, 832, 833
O31.43X9	Continuing pregnancy after vanishing twin syndrome of one fetus or more, third trimester, other fetus	N	14	817, 818, 819, 831, 832, 833
Q87.A	Loeys-Dietz syndrome	C	08	564, 565, 566
QA1.71	Lynch syndrome	N	23	951
QA1.790	Familial cancer syndrome with pathogenic BRCA1 mutation	N	23	951
QA1.791	Familial cancer syndrome with pathogenic BRCA2 mutation	N	23	951
QA1.792	Li Fraumeni syndrome	N	23	951
QA1.798	Other inherited neoplasm predisposition syndrome of multiple systems	N	23	951
R78.72	Abnormal gadolinium level in blood	N	23	947, 948
T52.811A	Toxic effect of alkenes, accidental (unintentional), initial encounter	N	21	917, 918
T52.811D	Toxic effect of alkenes, accidental (unintentional), subsequent encounter	N	23	949, 950
T52.811S	Toxic effect of alkenes, accidental (unintentional), sequela	N	21	922, 923
T52.812A	Toxic effect of alkenes, intentional self-harm, initial encounter	N	21	917, 918
T52.812D	Toxic effect of alkenes, intentional self-harm, subsequent encounter	N	23	949, 950
T52.812S	Toxic effect of alkenes, intentional self-harm, sequela	N	21	922, 923
T52.813A	Toxic effect of alkenes, assault, initial encounter	N	21	917, 918
T52.813D	Toxic effect of alkenes, assault, subsequent encounter	N	23	949, 950
T52.813S	Toxic effect of alkenes, assault, sequela	N	21	922, 923
T52.814A	Toxic effect of alkenes, undetermined, initial encounter	N	21	917, 918
T52.814D	Toxic effect of alkenes, undetermined, subsequent encounter	N	23	949, 950
T52.814S	Toxic effect of alkenes, undetermined, sequela	N	21	922, 923
T52.821A	Toxic effect of cycloparaffins, accidental (unintentional), initial encounter	N	21	917, 918
T52.821D	Toxic effect of cycloparaffins, accidental (unintentional), subsequent encounter	N	23	949, 950
T52.821S	Toxic effect of cycloparaffins, accidental (unintentional), sequela	N	21	922, 923
T52.822A	Toxic effect of cycloparaffins, intentional self-harm, initial encounter	N	21	917, 918
T52.822D	Toxic effect of cycloparaffins, intentional self-harm, subsequent encounter	N	23	949, 950
T52.822S	Toxic effect of cycloparaffins, intentional self-harm, sequela	N	21	922, 923
T52.823A	Toxic effect of cycloparaffins, assault, initial encounter	N	21	917, 918
T52.823D	Toxic effect of cycloparaffins, assault, subsequent encounter	N	23	949, 950
T52.823S	Toxic effect of cycloparaffins, assault, sequela	N	21	922, 923
T52.824A	Toxic effect of cycloparaffins, undetermined, initial encounter	N	21	917, 918
T52.824D	Toxic effect of cycloparaffins, undetermined, subsequent encounter	N	23	949, 950
T52.824S	Toxic effect of cycloparaffins, undetermined, sequela	N	21	922, 923
T52.891A	Toxic effect of other organic solvents, accidental (unintentional), initial encounter	N	21	917, 918
T52.891D	Toxic effect of other organic solvents, accidental (unintentional), subsequent encounter	N	23	949, 950
T52.891S	Toxic effect of other organic solvents, accidental (unintentional), sequela	N	21	922, 923
T52.892A	Toxic effect of other organic solvents, intentional self-harm, initial encounter	N	21	917, 918
T52.892D	Toxic effect of other organic solvents, intentional self-harm, subsequent encounter	N	23	949, 950
T52.892S	Toxic effect of other organic solvents, intentional self-harm, sequela	N	21	922, 923
T52.893A	Toxic effect of other organic solvents, assault, initial encounter	N	21	917, 918
T52.893D	Toxic effect of other organic solvents, assault, subsequent encounter	N	23	949, 950
T52.893S	Toxic effect of other organic solvents, assault, sequela	N	21	922, 923
T52.894A	Toxic effect of other organic solvents, undetermined, initial encounter	N	21	917, 918
T52.894D	Toxic effect of other organic solvents, undetermined, subsequent encounter	N	23	949, 950
T52.894S	Toxic effect of other organic solvents, undetermined, sequela	N	21	922, 923
T59.821A	Toxic effect of hexamethylene diisocyanate, accidental (unintentional), initial encounter	N	21	917, 918
""			22	928(5), 929(5)
T59.821D	Toxic effect of hexamethylene diisocyanate, accidental (unintentional), subsequent encounter	N	23	949, 950
T59.821S	Toxic effect of hexamethylene diisocyanate, accidental (unintentional), sequela	N	21	922, 923
T59.822A	Toxic effect of hexamethylene diisocyanate, intentional self-harm, initial encounter	N	21	917, 918
""			22	928(5), 929(5)
T59.822D	Toxic effect of hexamethylene diisocyanate, intentional self-harm, subsequent encounter	N	23	949, 950
T59.822S	Toxic effect of hexamethylene diisocyanate, intentional self-harm, sequela	N	21	922, 923
T59.823A	Toxic effect of hexamethylene diisocyanate, assault, initial encounter	N	21	917, 918
""			22	928(5), 929(5)
T59.823D	Toxic effect of hexamethylene diisocyanate, assault, subsequent encounter	N	23	949, 950
T59.823S	Toxic effect of hexamethylene diisocyanate, assault, sequela	N	21	922, 923
T59.824A	Toxic effect of hexamethylene diisocyanate, undetermined, initial encounter	N	21	917, 918
""			22	928(5), 929(5)
T59.824D	Toxic effect of hexamethylene diisocyanate, undetermined, subsequent encounter	N	23	949, 950
T59.824S	Toxic effect of hexamethylene diisocyanate, undetermined, sequela	N	21	922, 923
T65.851A	Toxic effect of medetomidine, accidental (unintentional), initial encounter	N	21	917, 918
T65.851D	Toxic effect of medetomidine, accidental (unintentional), subsequent encounter	N	23	949, 950
T65.851S	Toxic effect of medetomidine, accidental (unintentional), sequela	N	21	922, 923
T65.852A	Toxic effect of medetomidine, intentional self-harm, initial encounter	N	21	917, 918
T65.852D	Toxic effect of medetomidine, intentional self-harm, subsequent encounter	N	23	949, 950
T65.852S	Toxic effect of medetomidine, intentional self-harm, sequela	N	21	922, 923
T65.853A	Toxic effect of medetomidine, assault, initial encounter	N	21	917, 918
T65.853D	Toxic effect of medetomidine, assault, subsequent encounter	N	23	949, 950
T65.853S	Toxic effect of medetomidine, assault, sequela	N	21	922, 923
T65.854A	Toxic effect of medetomidine, undetermined, initial encounter	N	21	917, 918
T65.854D	Toxic effect of medetomidine, undetermined, subsequent encounter	N	23	949, 950
T65.854S	Toxic effect of medetomidine, undetermined, sequela	N	21	922, 923
Z68.18	Body mass index [BMI] 18.4 or less, adult	C	23	951
Z68.19	Body mass index [BMI] 18.5-19.9, adult	C	23	951
Z77.013	Contact with and (suspected) exposure to gadolinium	N	23	951
Z77.32	Contact with and (suspected) exposure to burn pits in war theater	N	23	951
Z77.33	Contact with and (suspected) exposure to Agent Orange	N	23	951
Z77.40	Contact with and (suspected) exposure to unspecified blast overpressure	N	23	951
Z77.41	Contact with and (suspected) exposure to low-level blast overpressure	N	23	951
Z77.42	Contact with and (suspected) exposure to high-level blast overpressure	N	23	951
Z77.49	Contact with and (suspected) exposure to other blast overpressure	N	23	951
Z86.17	Personal history of Clostridioides difficile infection	N	23	951
Z87.8901	Personal history of social gender transition	N	19	887
Z87.8902	Personal history of medical gender transition	N	19	887
Z87.8903	Personal history of surgical gender transition	N	19	887
Z87.8904	Personal history of intersex surgery	N	19	887
Z87.8909	Personal history of unspecified gender transition	N	19	887
Z87.893	Personal history of gender detransition	N	23	951

	Notes:
	(1)-On newborn major problem list
	(2)-On 'Only Secondary Diagnosis' list
	(3)-In combination with SDX of HIV
	(4)-On 'Principal Diagnosis' list
	(5)-On 'Secondary Diagnosis' list